Despite these limitations attributed to logistical challenges of obtaining follow-up blood donations in Bangladesh patients after recovery from COVID-19, the results in this study underscore the reliability of the N-protein immunoassay for the detection of N-protein specific IgA and IgG during natural SARS-CoV-2 infection. This evidence concerns the gene CD79A and COVID-19.